Price (delayed)
$0.13
Market cap
$1.84M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$6.67
Enterprise value
$1.77M
mymd is a clinical stage biotech pharmaceutical company committed to extending healthy lifespan by focusing on developing two therapeutic platforms. mymd-1 is a drug platform based on a clinical stage
There are no recent dividends present for TNFA.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.